How AI-Powered Spatial Insights Are Being Integrated into Drug Development and Diagnostics

Time: 12:00 pm
day: Day One


  • Examples of how the new wave of therapeutics such as antibody-drug conjugates (ADCs), multispecifics, and immunotherapy can benefit from AI-based spatial analysis of patient biopsies for extracting biomarker signatures that can predict response
  • How AI-based multimodal integration of different pathology and spatial data modalities (e.g., H&E, immunohistochemistry, multiplex immunofluorescence, spatial transcriptomics) can enhance the information derived from each tissue sample
  • How digital pathology standardization efforts and integration of multiplex immunofluorescence assays in clinical trial enrollment can drive the field of pathology-based diagnostics into the new digital biology era